Could a growth hormone booster shrink dangerous liver fat?
NCT ID NCT05364684
Summary
This small pilot study tested whether a drug called ibutamoren could reduce fat buildup in the livers of people with nonalcoholic fatty liver disease (NAFLD). Researchers enrolled 12 generally healthy adults with NAFLD to take the drug for 6 months. The main goal was to see if liver fat, measured by a special MRI scan, decreased during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC FATTY LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.